Blackrock, INC Schedule 13G passive stakes
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, revealing a 12.7% beneficial ownership stake in Titan International Inc. as of December 31, 2024, held for ordinary business purposes.
NYSE
SCHEDULE 13G/A: BlackRock Discloses Passive 2.9% Stake in ESSA Bancorp, Inc.
BlackRock, Inc. has filed an amended Schedule 13G, reporting a passive beneficial ownership of 2.9% of ESSA Bancorp, Inc.'s common stock as of December 31, 2024.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 6.8% beneficial ownership stake in Canadian Solar Inc. as of December 31, 2024.
NYSE
SCHEDULE 13G/A: BlackRock Maintains Significant 7.8% Stake in Energy Fuels Inc.
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a beneficial ownership of 7.8% in Energy Fuels Inc.'s common stock as of December 31, 2024.
NYSE
SCHEDULE 13G/A: BlackRock, Inc. Discloses 7.0% Stake in Vermilion Energy Inc.
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 7.0% beneficial ownership stake in Vermilion Energy Inc. as of December 31, 2024.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 16.3% Stake in MAC Copper Ltd
BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 16.3% of MAC Copper Ltd's common stock as of December 31, 2024.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, revealing a beneficial ownership of 5.8% of WNS Holdings Ltd's common stock as of December 31, 2024.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 8.7% Stake in Patria Investments Limited
BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 8.7% in Patria Investments Limited as of December 31, 2024.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 6.1% beneficial ownership stake in Wave Life Sciences Ltd. as of December 31, 2024.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 7.3% Stake in Alerus Financial Corp
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 7.3% beneficial ownership stake in Alerus Financial Corp as of December 31, 2024.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, revealing its beneficial ownership of 9.7% of AngioDynamics Inc.'s common stock as of December 31, 2024.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 8.0% Stake in Applied Therapeutics Inc.
BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 8.0% of Applied Therapeutics Inc.'s common stock as of December 31, 2024.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 18.3% Stake in Armada Hoffler Properties
BlackRock, Inc. has filed an amended Schedule 13G, revealing a beneficial ownership of 18.3% of Armada Hoffler Properties Inc.'s common stock as of December 31, 2024.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 6.5% Passive Stake in Capricor Therapeutics
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 6.5% beneficial ownership stake in Capricor Therapeutics Inc. as of December 31, 2024.
NYSE
SCHEDULE 13G/A: BlackRock Discloses Reduced Passive Stake in Cardiff Oncology, Inc. Below 5% Threshold
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 4.3% passive beneficial ownership stake in Cardiff Oncology, Inc. as of December 31, 2024.
NYSE
SCHEDULE 13G/A: BlackRock Amends Passive Stake in Coastal Financial Corp to 7.2%
BlackRock, Inc. has filed an Amendment No. 3 to Schedule 13G, disclosing a 7.2% beneficial ownership stake in Coastal Financial Corp as of December 31, 2024.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 9.7% passive beneficial ownership stake in CommScope Holding Company, Inc. as of December 31, 2024.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, revealing its beneficial ownership of 9.7% of Community Healthcare Trust Inc.'s common stock as of December 31, 2024.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 11.7% of Confluent, Inc.'s Class A Common Stock as of December 31, 2024.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 9.0% Passive Stake in Coursera, Inc.
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 9.0% passive beneficial ownership stake in Coursera, Inc. as of December 31, 2024.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 12.7% Stake in CTO Realty Growth, Inc.
BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 12.7% of CTO Realty Growth, Inc.'s common stock as of December 31, 2024.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 8.2% Passive Stake in fuboTV Inc.
BlackRock, Inc. has filed an updated Schedule 13G, revealing a passive beneficial ownership of 8.2% of fuboTV Inc.'s common stock as of December 31, 2024.
NYSE
BlackRock, Inc. has filed an Amendment No. 14 to its Schedule 13G, disclosing a 14.4% beneficial ownership stake in HCI Group, Inc. as of December 31, 2024.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 5.3% Passive Stake in INOVIO PHARMACEUTICALS
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 5.3% beneficial ownership stake in INOVIO PHARMACEUTICALS INC as of December 31, 2024.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 0.5% Passive Stake in iShares CMBS ETF
BlackRock, Inc. has filed an amended Schedule 13G, reporting a passive beneficial ownership of 0.5% in the iShares CMBS ETF as of December 31, 2024.
NYSE
SCHEDULE 13G/A: BlackRock Amends Schedule 13G, Disclosing 9.1% Stake in iShares Broad USD High Yield Corporate Bond ETF
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 9.1% beneficial ownership stake in the iShares Broad USD High Yield Corporate Bond ETF as of December 31, 2024.
NYSE
BlackRock, Inc. has filed an amendment to its Schedule 13G, confirming a 12.7% beneficial ownership stake in Kilroy Realty Corp. as of December 31, 2024.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, revealing a beneficial ownership of 19.6% of Koppers Holdings Inc.'s common stock as of December 31, 2024.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 9.8% Stake in Landsea Homes Corp
BlackRock, Inc. has filed an amended Schedule 13G, revealing a beneficial ownership of 9.8% of Landsea Homes Corp's common stock as of December 31, 2024.
NYSE
SCHEDULE 13G/A: BlackRock Amends Passive Stake in Lineage Cell Therapeutics, Reports 4.6% Beneficial Ownership
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 4.6% beneficial ownership stake in Lineage Cell Therapeutics Inc. as of December 31, 2024.